Investigators sought to better understand how race and ethnicity was related to the severity of rosacea phenotypes among adults.

Dermatologists should take action to treat patients who present with cutaneous manifestations of metabolic disease, according ...

Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Infiltrating Lymphocyte Scoring Improves Progression Risk Prediction in Stage II Melanoma: A Retrospective Cohort Study,” published in the March 2025 issue of Journal of the American Academy of ...

The study evaluates 20 years of the US Food and Drug Administration (FDA) Adverse Event Reporting System data.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

Patients with vitiligo who received long-term NBUVB phototherapy vs no phototherapy were associated with reduced risks for cardiometabolic diseases.

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows. This regimen ...

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...